ImmunoPrecise Antibodies (STU:TQB) Scaled Net Operating Assets : 0.76 (As of Oct. 2024)

ImmunoPrecise Antibodies Scaled Net Operating Assets Chart

ImmunoPrecise Antibodies Annual Data
	Trend	Dec14	Dec15	Apr17	Apr18	Apr19	Apr20	Apr21	Apr22	Apr23	Apr24
Scaled Net Operating Assets		Get a 7-Day Free Trial					0.59	0.70	0.79	0.56	0.57

ImmunoPrecise Antibodies Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.73	0.76	0.56	0.74	0.76

Competitive Comparison of ImmunoPrecise Antibodies's Scaled Net Operating Assets

For the Biotechnology subindustry, ImmunoPrecise Antibodies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmunoPrecise Antibodies's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmunoPrecise Antibodies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where ImmunoPrecise Antibodies's Scaled Net Operating Assets falls into.

ImmunoPrecise Antibodies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

ImmunoPrecise Antibodies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Apr. 2024 is calculated as

where

ImmunoPrecise Antibodies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Oct. 2024 is calculated as

where

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ImmunoPrecise Antibodies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of ImmunoPrecise Antibodies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmunoPrecise Antibodies Business Description